Form 8-K - Current report:
SEC Accession No. 0001962918-24-000104
Filing Date
2024-08-13
Accepted
2024-08-13 16:14:49
Documents
15
Period of Report
2024-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K slrn-20240809.htm   iXBRL 8-K 38984
2 EX-10.1 slrn-8kx8132024xexx101.htm EX-10.1 88933
3 EX-99.1 slrn-8kx8132024xexx991.htm EX-99.1 67407
  Complete submission text file 0001962918-24-000104.txt   356183

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20240809.xsd EX-101.SCH 1892
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20240809_lab.xml EX-101.LAB 22530
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20240809_pre.xml EX-101.PRE 13037
17 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20240809_htm.xml XML 2815
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 241201632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)